ABSTRACT
BACKGROUND AND OBJECTIVES: Hepatitis A virus (HAV) transmission via contaminated blood products has been reported. Cell-adapted HAV strains are generally used to confirm virus inactivation in manufacturing blood products, but the strains may differ in their sensitivity to inactivation treatment. To select an appropriate cell-adapted HAV strain for virus validation, we compared the inactivation efficiency among four strains under two different physical inactivation treatments: heat and high hydrostatic pressure. MATERIALS AND METHODS: The cell-adapted HAV strains used here were KRM238, KRM003 (subgenotype IIIB), KRM031 (IA), and TKM005 (IB). The strains were treated at 60 degrees C for up to 10 h or under high hydrostatic pressure (up to 420 MPa). The reduction in HAV infectivity was measured by an immunofocus-staining method. RESULTS: The heat treatment at 60 degrees C for 10 h reduced HAV infectivity in the range of 3 to 5 log(10) among the strains; KRM238 and TKM005 were harder to inactivate than the other two. The high hydrostatic pressure treatment at 420 MPa also reduced infectivity in the range of 3 to 5 log(10) among the strains, and KRM031 was easier to inactivate than the other strains. CONCLUSION: Heat treatment and high hydrostatic pressure treatment revealed differences in inactivation efficiencies among cell-adapted HAV strains, and each strain reacted differently depending on the treatment. KRM238 may be the best candidate for virus validation to ensure the safety of blood products against viral contamination, as it is harder to inactivate and it replicates better in cell culture than the other strains.
Subject(s)
Blood Safety/methods , Hepatitis A virus/physiology , Hot Temperature , Hydrostatic Pressure , Virus Inactivation , Animals , Cell Line , Chlorocebus aethiops , Hepatitis A virus/classification , Hepatitis A virus/growth & development , Kidney , Species Specificity , Virus CultivationABSTRACT
In this article, we examined the distribution of myofibroblasts and CD34-positive stromal cells in normal renal pelvis and ureter and their cancers using immunohistochemistry. Eighteen tumors and normal tissues apart from the main tumor were examined. In the wall of normal renal pelvis and ureter, no myofibroblasts were observed through all layers, but CD34-positive stromal cells were observed in the deep area of lamina propria, muscular layer and adventitia. In the stroma of renal pelvic and ureteral cancers, myofibroblasts were distributed in fifteen tumors and were absent in three tumors. All three tumors containing no myofibroblasts in the stroma were non-invasive type and all invasive cancers contained myofibroblasts in the stroma. CD34-positive stromal cells were consistently absent in the stroma of cancers, irrespective of the invasiveness. Finally, myofibroblasts are major stromal components in renal pelvic and ureteral cancers, particularly in invasive cancers, and CD34-positive stromal cells are consistently absent or lost in the stroma of their cancers. These findings suggest that the invasion of renal pelvic and ureteral cancers may cause the phenotypic change of stromal cells.
Subject(s)
Antigens, CD34 , Fibroblasts/pathology , Kidney Neoplasms/pathology , Pelvic Neoplasms/pathology , Stromal Cells/pathology , Ureteral Neoplasms/pathology , Aged , Aged, 80 and over , Female , Fibroblasts/cytology , Humans , Immunohistochemistry , Male , Middle Aged , Neoplasm Invasiveness/pathology , Stromal Cells/cytology , UrotheliumABSTRACT
The presence of myofibroblasts has been elucidated in the stroma of neoplasm of various organs. In the present article, we studied the distribution of myofibroblasts in the stroma of bladder carcinoma. Twenty-five surgical resected bladder tumors (urothelial carcinoma, n = 21; combined urothelial carcinoma and adenocarcinoma, n = 2; sarcomatoid squamous cell carcinoma, n = 1; combined urothelial carcinoma and squamous cell carcinoma, n = 1) were selected and we evaluated the distribution of myofibroblasts using immunohistochemical, electron and immunoelectron microscopic techniques. Immunohistochemically, the distribution pattern of myofibroblasts in invasive and non-invasive carcinomas were predominantly fascicular and reticular forms, respectively. Moreover, myofibroblasts around bladder carcinoma cells were confirmed by electron microscope. Understanding the distribution pattern of myofibroblasts in the stroma of bladder carcinoma may provide available information about the presence of carcinoma invasion.
Subject(s)
Adenocarcinoma/pathology , Carcinoma, Squamous Cell/pathology , Fibroblasts/pathology , Myocytes, Smooth Muscle/pathology , Urinary Bladder Neoplasms/pathology , Actins/analysis , Adenocarcinoma/chemistry , Adenocarcinoma/ultrastructure , Aged , Aged, 80 and over , Calmodulin-Binding Proteins/analysis , Carcinoma, Squamous Cell/chemistry , Carcinoma, Squamous Cell/ultrastructure , Female , Fibroblasts/chemistry , Fibroblasts/ultrastructure , Humans , Immunohistochemistry , Male , Microscopy, Electron , Middle Aged , Myocytes, Smooth Muscle/chemistry , Myocytes, Smooth Muscle/ultrastructure , Stromal Cells/chemistry , Stromal Cells/pathology , Urinary Bladder Neoplasms/chemistry , Urinary Bladder Neoplasms/ultrastructureSubject(s)
Bone Density Conservation Agents/therapeutic use , Diphosphonates/therapeutic use , Imidazoles/therapeutic use , Intracellular Signaling Peptides and Proteins/genetics , Leukemia, Myelomonocytic, Acute , Mutation , Protein Tyrosine Phosphatases/genetics , Child, Preschool , Humans , Leukemia, Myelomonocytic, Acute/drug therapy , Leukemia, Myelomonocytic, Acute/enzymology , Leukemia, Myelomonocytic, Acute/genetics , Male , Protein Tyrosine Phosphatase, Non-Receptor Type 11 , SH2 Domain-Containing Protein Tyrosine Phosphatases , Treatment Outcome , Zoledronic Acid , src Homology DomainsABSTRACT
The presence of myofibroblasts has been elucidated in neoplastic capsules of various organs. In the present article, we examine the presence of myofibroblasts in the capsule of renal cell carcinoma (RCC) and discuss the origin of the myofibroblasts. Nineteen renal tumors (conventional RCC, n=17; chromophobe RCC, n=2) with evident and totally surrounded fibrous capsule were selected. Abundant myofibroblasts were immunohistochemically observed in the capsule of the RCCs. These findings were confirmed by electron and immunoelectron microscopic studies of three conventional RCCs. Type III and I collagens were predominant in the outer and inner layers of the RCC capsule, respectively. The cytoplasm of the tubular epithelial cells in the tissue surrounding the neoplastic capsule stained positively for transforming growth factor (TGF)-beta 1. In situ hybridization detected type I collagen mRNA in myofibroblasts of the capsule. Myofibroblasts may participate in the capsular formation of conventional and chromophobe RCCs through the collagen production.
Subject(s)
Carcinoma, Renal Cell/pathology , Fibroblasts/pathology , Carcinoma, Renal Cell/metabolism , Carcinoma, Renal Cell/ultrastructure , Collagen/metabolism , Fibroblasts/metabolism , Fibroblasts/ultrastructure , Humans , Microscopy, ImmunoelectronABSTRACT
The combination of an asymmetric crying face and heart defect has been termed cardiofacial syndrome. This "syndrome" is etiologically heterogeneous and a subset of patients have 22q111.2 deletions. We present a female with Cayler's cardiofacial syndrome phenotype who had a frameshift mutation of the EYA1 gene. We conclude that EYA1 mutation represents a previously undescribed cause of cardiofacial syndrome.
Subject(s)
Branchio-Oto-Renal Syndrome/genetics , Facial Asymmetry/congenital , Facial Asymmetry/genetics , Heart Defects, Congenital/genetics , Point Mutation/genetics , Trans-Activators/genetics , DNA Mutational Analysis , Diagnosis, Differential , Female , Humans , Infant, Newborn , Intracellular Signaling Peptides and Proteins , Nuclear Proteins , Phenotype , Protein Tyrosine Phosphatases , Sequence Deletion/geneticsABSTRACT
We have found steroid pulse therapy to be effective and safe for local and systemic adverse reactions of BCG therapy. Two cases are reported. Case 1: A 57-year-old woman with initial recurrence of urinary bladder carcinoma was treated with transurethral resection. The histopathological findings were transitional cell carcinoma (TCC), G2 > G1, pT1a. To prevent a second recurrence, she was administered Bacillus Calmette-Guerin (BCG) instillation therapy: 80 mg of BCG, (Tokyo strain) suspended in 40 ml of normal saline, instilled into her bladder weekly. After the fifth week of instillation, she was found to have a cough, sputum, edema of the eyelids, congestion of palpebral conjunctive, severe pain on micturition and pollakisuria. Although she was administered antituberculus, antibiotics and antiallergic drugs, all sign and symptoms were aggravated. Blood, urine and sputum cultures remained negative for mycobacterium. She was later diagnosed as having hypersensitive reactions against BCG and treated with steroid pulse therapy. The signs and symptoms mentioned above were decreased immediately and disappeared after a week. Case 2: A 76-year-old man with initial recurrence of urinary bladder carcinoma was treated with transurethral resection. To prevent a second recurrence, he was instilled the BCG six (6) times. Although no adverse reaction was observed, urinary cytology remained positive (class V) and small papillary tumor was detected at the dome of the bladder. Transurethral biopsy was then performed. The histopathological findings showed TCC, G3, CIS on the dome of bladder. Then he was again administered the same BCG instillation therapy. After the fifth instillation, he complained of severe pain of micturition, pollakisuria and dysuria. Although he was administered antibiotics and antiinflammatory drugs, all signs and symptoms were aggravated. Urine culture remained negative for mycobacterium. He was diagnosed as having hypersensitive reactions against BCG and was treated with two times of steroid pulse therapy. The signs and symptoms mentioned above were decreased immediately and disappeared after the second steroid pulse therapy.
Subject(s)
Adjuvants, Immunologic/adverse effects , BCG Vaccine/adverse effects , Carcinoma, Transitional Cell/therapy , Hypersensitivity/drug therapy , Methylprednisolone/administration & dosage , Prednisolone/administration & dosage , Urinary Bladder Neoplasms/therapy , Administration, Intravesical , Aged , Female , Humans , Hypersensitivity/etiology , Male , Middle Aged , Pulse Therapy, DrugABSTRACT
Many proteins involved in eukaryotic transcription are similar in function and in sequence between organisms. Despite the sequence similarities, there are many factors that do not function across species. For example, transcript elongation factor TFIIS is highly conserved among eukaryotes, and yet the TFIIS protein from Saccharomyces cerevisiae cannot function with mammalian RNA polymerase II and vice versa. To determine the reason for this species specificity, chimeras were constructed linking three structurally independent regions of the TFIIS proteins from yeast and human cells. Two independently folding domains, II and III, have been examined previously using NMR (). Yeast domain II alone is able to bind yeast RNA polymerase II with the same affinity as the full-length TFIIS protein, and this domain was expected to confer the species selectivity. Domain III has previously been shown to be readily exchanged between mammalian and yeast factors. However, the results presented here indicate that domain II is insufficient to confer species selectivity, and a primary determinant lies in a 30-amino acid highly conserved linker region connecting domain II with domain III. These 30 amino acids may physically orient domains II and III to support functional interactions between TFIIS and RNA polymerase II.
Subject(s)
Transcription Factors, General , Transcription Factors/physiology , Transcriptional Elongation Factors , Amino Acid Sequence , Conserved Sequence , HeLa Cells , Humans , Molecular Sequence Data , Protein Conformation , RNA Polymerase II/metabolism , Recombinant Fusion Proteins/chemistry , Saccharomyces cerevisiae , Species Specificity , Structure-Activity Relationship , Transcription Factors/geneticsABSTRACT
The transcriptionally active fragment of the yeast RNA polymerase II transcription elongation factor, TFIIS, comprises a three-helix bundle and a zinc ribbon motif joined by a linker region. We have probed the function of this fragment of TFIIS using structure-guided mutagenesis. The helix bundle domain binds RNA polymerase II with the same affinity as does the full-length TFIIS, and this interaction is mediated by a basic patch on the outer face of the third helix. TFIIS mutants that were unable to bind RNA polymerase II were inactive for transcription activity, confirming the central role of polymerase binding in the TFIIS mechanism of action. The linker and zinc ribbon regions play roles in promoting cleavage of the nascent transcript and read-through past the block to elongation. Mutation of three aromatic residues in the zinc ribbon domain (Phe269, Phe296, and Phe308) impaired both transcript cleavage and read-through. Mutations introduced in the linker region between residues 240 and 245 and between 250 and 255 also severely impaired both transcript cleavage and read-through activities. Our analysis suggests that the linker region of TFIIS probably adopts a critical structure in the context of the elongation complex.
Subject(s)
RNA Polymerase II/metabolism , Saccharomyces cerevisiae/metabolism , Transcription Factors, General , Transcription Factors/metabolism , Transcriptional Elongation Factors , Models, Molecular , Mutagenesis, Site-Directed , Protein Binding , RNA, Messenger/metabolism , Structure-Activity Relationship , Transcription Factors/chemistry , Transcription Factors/genetics , Zinc/chemistryABSTRACT
The micropig model of chronic alcoholism was used to study the relationship of lipid composition and physical properties in three different tissue membranes from the same animals. Ethanol feeding reduced membrane anisotropy, as measured with the diphenylhexatriene probe, in liver plasma and kidney brush-border membranes but not in jejunal brush-border membranes. Preincubation with ethanol reduced anisotropy in each of the three control membranes, whereas all three membranes from the ethanol-fed group were relatively tolerant to the acute effect of ethanol. In liver and kidney membranes, ethanol feeding increased levels of linoleic (18:2 omega 6) acid and decreased levels of arachidonic (20:4 omega 6) and docosahexaenoic (22:6 omega 3) acids and their specific double-bond positions, consistent with reduced activities of delta 6 and delta 5 fatty acid desaturases. In liver and kidney membranes, anisotropy parameters and the acute effect of ethanol correlated inversely with levels of linoleic acid and directly with levels of arachidonic and docosahexaenoic acids and their specific double bonds. Levels of docosahexaenoic acid correlated with the acute effect of ethanol in all three membranes. Phospholipid fatty acid profiles were similar in jejunal brush-border membranes and terminal bile samples, suggesting that the effects of ethanol on jejunal fatty acids and physical properties are modulated by intraluminal biliary phospholipids. The effect of ethanol on anisotropy could not be attributed to changes in membrane cholesterol/phospholipid ratios. These studies affirm the value of this new animal model of chronic alcoholism and provide comprehensive evidence for the central role of fatty acid desaturation in the membrane-associated effects of ethanol exposure.